Effects of Hypervapotron Geometry on Thermalhydraulic Performance von Youchison, D. L., Ulrickson, M. A., Bullock, J. H.

Volltext

A Comparison of Two-Phase Computational Fluid Dynamics Codes Applied to the ITER First Wall Hypervapotron von Youchison, Dennis L, Ulrickson, Michael A, Bullock, James H

Volltext

Detailed 3-D nuclear analysis of ITER outboard blanket modules von Bohm, Tim, Davis, Andrew, Sawan, Mohamed, Marriott, Edward, Wilson, Paul, Ulrickson, Michael, Bullock, James

Volltext

A comparison of two-phase computational fluid dynamics codes applied to the ITER first wall hypervapotron von Bullock, James H., Youchison, Dennis Lee, Ulrickson, Michael Andrew

Volltext

Electromagnetic Analysis of Forces and Torques on the Baseline and Enhanced ITER Shield Modules due to Plasma Disruption von Kotulski, Joseph D, Coats, Rebecca S, Pasik, Michael F, Ulrickson, Michael

Volltext

Electromagnetic analysis of forces and torques on the baseline and enhanced ITER shield modules due to plasma disruption von Kotulski, Joseph Daniel, Coats, Rebecca Sue, Pasik, Michael Francis, Ulrickson, Michael Andrew

Volltext

The analysis of the electromagnetic loads on selected ITER blanket shield modules due to induced eddy and halo currents von Kotulski, J. D., Coats, R., Ulrickson, M.

Volltext

First Wall Qualification Testing at SNL von Tanaka, T.J., Ying, A., Narula, M., Ulrickson, M.A.

Volltext

Finite Element Stress Analysis OF ITER Module 13 von Garde, J., Youchison, D., Natoni, G., Bullock, J., Tanaka, T.J., Ulrickson, M.A., Narula, M., Ying, A., Sawan, M., Wilson, P.

Volltext

Technical opportunities for international collaborations by the U.S. Fusion program von SAUTHOFF, Ned, BAKER, Charles, NEVINS, William, SMITH, Dale, ULRICKSON, Michael, VAN DAM, James, WURDEN, Glen, YOUNG, Kenneth, BAKER, Dan, BENGSTON, Roger, BLOOM, Everett, DRAKE, James, FALTENS, Andy, GRANETZ, Robert, LYON, James, MIODUSZEWSKI, Peter

Volltext

Extreme-UV electrical discharge source von NYGREN RICHARD E, FORNACIARI NEAL R, ULRICKSON MICHAEL A

Volltext bestellen

Tokamak plasma current disruption infrared control system von KUGEL, HENRY W, ULRICKSON, MICHAEL

Volltext bestellen

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial von Neelapu, Sattva S., Dickinson, Michael, Munoz, Javier, Ulrickson, Matthew L., Thieblemont, Catherine, Oluwole, Olalekan O., Herrera, Alex F., Ujjani, Chaitra S., Lin, Yi, Riedell, Peter A., Kekre, Natasha, de Vos, Sven, Lui, Christine, Milletti, Francesca, Dong, Jinghui, Xu, Hairong, Chavez, Julio C.

Volltext

Extreme-uv electrical discharge source von NEAL R. FORNACIARI, RICHARD E. NYGREN, MICHAEL A. ULRICKSON

Volltext bestellen

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma von Westin, Jason R, Locke, Frederick L, Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David B, Ulrickson, Matthew L, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori, Kersten, Marie José, Jacobson, Caron A, Pagel, John M, Wulf, Gerald, Johnston, Patrick, Rapoport, Aaron P, Du, Linqiu, Vardhanabhuti, Saran, Filosto, Simone, Shah, Jina, Snider, Julia T, Cheng, Paul, To, Christina, Oluwole, Olalekan O, Sureda, Anna

Volltext

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma von Locke, Frederick L, Miklos, David B, Jacobson, Caron A, Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O, Ghobadi, Armin, Rapoport, Aaron P, McGuirk, Joseph, Pagel, John M, Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M, Sureda, Anna, Flinn, Ian W, Vandenberghe, Peter, Song, Kevin W, Dickinson, Michael, Minnema, Monique C, Riedell, Peter A, Leslie, Lori A, Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I, Westin, Jason R

Volltext

KITE-363: A phase 1 study of an autologous anti-CD19/CD20 chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (R/R) B-cell lymphoma (BCL) von Nastoupil, Loretta J., Dahiya, Saurabh, Miklos, David Bernard, Reagan, Patrick Michael, Ulrickson, Matthew, Jung, A. Scott, Kloos, Ioana, Dong, Jinghui, Chou, Justin, Murakami, Jodi, Rodriguez, Katherine, Nahas, Myrna

Volltext

3-Year Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL) von Chavez, Julio C., Dickinson, Michael, Munoz, Javier L., Ulrickson, Matthew L., Thieblemont, Catherine, Oluwole, Olalekan O., Herrera, Alex F., Ujjani, Chaitra S, Lin, Yi, Riedell, Peter A., Kekre, Natasha K., de Vos, Sven, Lui, Christine, Wulff, Jacob, Williams, Chad M., Peng, Weixin, Kloos, Ioana, Xu, Hairong, Neelapu, Sattva S.

Volltext

Clinical and patient (pt)-reported outcomes (PROs) in a phase 3, randomized, open-label study evaluating axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in... von Westin, Jason, Locke, Frederick L., Dickinson, Michael, Ghobadi, Armin, Elsawy, Mahmoud, van Meerten, Tom, Miklos, David Bernard, Ulrickson, Matthew, Perales, Miguel-Angel, Farooq, Umar, Wannesson, Luciano, Leslie, Lori Ann, Kersten, Marie José, Jacobson, Caron Alyce, Pagel, John M., Wulf, Gerald, Du, Linqiu, Snider, Julia, To, Christina Ann, Oluwole, Olalekan O.

Volltext

Interim Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) as First-Line Therapy in Patients (Pts) With High-Risk Large B Cell Lymphoma (LBCL) von Neelapu, Sattva S., Dickinson, Michael, Ulrickson, Matthew L., Oluwole, Olalekan O., Herrera, Alex F., Thieblemont, Catherine, Ujjani, Chaitra S., Lin, Yi, Riedell, Peter A., Kekre, Natasha, de Vos, Sven, Yang, Yin, Milletti, Francesca, Goyal, Lovely, Kawashima, Jun, Chavez, Julio C.

Volltext